Issued Patents 2021
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11192955 | Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors | David M. Goldenberg | 2021-12-07 |
| RE48751 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2021-09-28 |
| 11116846 | Antibody-drug conjugates and uses thereof | David M. Goldenberg | 2021-09-14 |
| 11077201 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2021-08-03 |
| 11066468 | Immunoconjugates with an intracellularly-cleavable linkage | — | 2021-07-20 |
| 11052156 | Antibody-drug conjugates and uses thereof | David M. Goldenberg | 2021-07-06 |
| 11052081 | Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132) | David M. Goldenberg | 2021-07-06 |
| 11020489 | Immunoconjugates with an intracellularly-cleavable linkage | Sung-Ju Moon, David M. Goldenberg | 2021-06-01 |
| 10918721 | Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity | David M. Goldenberg | 2021-02-16 |